IAN T. BOTHWELL - 13 May 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
OCEL
Transactions as of
13 May 2021
Transactions value $
-$42,492
Form type
4
Filing time
20 May 2021, 21:45:40 UTC
Previous filing
12 May 2021
Next filing
25 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale -$11K -50K -0.03% $0.22 150M 18 May 2021 Direct
transaction OCEL Common Stock Sale -$12K -50K -0.03% $0.24 149M 19 May 2021 Direct
transaction OCEL Common Stock Sale -$5K -25K -0.02% $0.20 149M 19 May 2021 Direct
transaction OCEL Common Stock Sale -$9.5K -50K -0.03% $0.19 149M 20 May 2021 Direct
transaction OCEL Common Stock Sale -$4.99K -26.3K -0.02% $0.19 149M 20 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.